Glial-Derived Neurotrophic Factor Human Recombinant
Glial-Derived Neurotrophic Factor Human Recombinant, Sf9
GDNF Human Recombinant produced in Baculovirus is a single glycosylated polypeptide chain containing 113amino acids (109-211 aa) and having a molecular mass of 12.8kDa.
GDNF is fused to an 10 amino acid His tag at C-terminus and purified by proprietary chromatographic techniques.
Sf9, Baculovirus cells.
Glial-Derived Neurotrophic Factor Mouse Recombinant
Glial-Derived Neurotrophic Factor Rat Recombinant
GDNF Family Receptor Alpha 1 Human Recombinant
GFRA1 Human Recombinant produced in HEK293 cells is a single, glycosylated polypeptide chain (a.a 25-423) containing 409 amino acids including a 10 a.a C-terminal His tag. The total molecular mass is 46.0kDa (calculated).
HEK293 cells.
GDNF Family Receptor Alpha 1 Rat Recombinant
GFRA1 Rat Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 645 amino acids (25-430a.a.) and having a molecular mass of 72.3kDa (Molecular size on SDS-PAGE will appear at approximately 70-100kDa). GFRA1 is expressed with a 239 amino acid hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques.
Sf9, Baculovirus cells.
GDNF Family Receptor Alpha 3 Human Recombinant
GDNF Family Receptor Alpha 3 Human Recombinant, Sf9
GFRA3 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 585 amino acids (32-374) and having a molecular mass of 65.5kDa (Molecular size on SDS-PAGE will appear at approximately 70-100kDa). GFRA3 is fused to a 239 amino acid hIgG-His-Tag at C-terminus and purified by proprietary chromatographic techniques.
Glial cell line-derived neurotrophic factor (GDNF) is a protein encoded by the GDNF gene in humans. It belongs to the GDNF family of ligands (GFL), which also includes neurturin (NRTN), artemin (ARTN), and persephin (PSPN) . GDNF is classified as a neurotrophic factor, which means it promotes the survival, development, and function of neurons .
Key Biological Properties: GDNF is a small protein that potently promotes the survival of various types of neurons, particularly dopaminergic neurons . It signals through GFRα receptors, especially GFRα1 .
Expression Patterns and Tissue Distribution: GDNF is highly distributed throughout both the peripheral and central nervous systems. It can be secreted by astrocytes, oligodendrocytes, Schwann cells, motor neurons, and skeletal muscle during the development and growth of neurons and other peripheral cells .
Primary Biological Functions: GDNF is crucial for the survival of dopaminergic and motor neurons. It prevents apoptosis in motor neurons during development, decreases the overall loss of neurons, rescues cells from axotomy-induced death, and prevents chronic degeneration .
Role in Immune Responses and Pathogen Recognition: While GDNF’s primary role is in neuronal survival and development, it also has functions outside the nervous system, such as in kidney morphogenesis and spermatogenesis .
Mechanisms with Other Molecules and Cells: GDNF binds to GFRα1, forming a complex that interacts with the RET receptor tyrosine kinase . This interaction activates several intracellular signaling pathways, including the ERK-1 and ERK-2 isoforms of MAP kinase, P13K/AKT pathways, and Src-family kinases .
Binding Partners and Downstream Signaling Cascades: GDNF can also signal through the neural cell adhesion molecule (NCAM) in cells lacking RET, activating Fyn and FAK .
Regulatory Mechanisms Controlling Expression and Activity: The activity of GDNF is mediated by the RET receptor tyrosine kinase, and GDNF must be bound to GFRα1 for the receptor to modulate its activity . The neurotrophic effect of GDNF requires the presence of transforming growth factor β, which activates the transport of GFRα1 to the cell membrane .
Transcriptional Regulation and Post-Translational Modifications: GDNF is first synthesized as a precursor protein (pro-GDNF) and undergoes a series of protein cleavage and processing to become the active and mature form .
Biomedical Research: GDNF has been extensively studied for its potential therapeutic applications in neurodegenerative diseases, particularly Parkinson’s disease . It has shown promise in protecting and regenerating dopamine-producing brain cells .
Diagnostic Tools and Therapeutic Strategies: GDNF is being explored as a therapeutic agent delivered through gene therapy or direct protein infusion to treat Parkinson’s disease .